Search

everythinglearnresearchcommunity

for

Search:↓

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

FOL-005 peptide may help treat excessive hair growth safely.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

H19 may help cause PCOS by affecting CTGF levels, suggesting a new treatment target.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Finasteride blocks progesterone's effect on absence seizures in rats.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Low PON1 levels may indicate and predict the severity of hair loss.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Bicalutamide improves hair density in women safely.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Effective PCOS treatments require targeting specific signaling pathways.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Berberine may be a safe and effective treatment for male pattern baldness.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.